Mono Pharmacare (NSE:MONOPHARMA) Forward Dividend Yield %: 0.00% (As of Jul. 08, 2026)


NSE:MONOPHARMA Mono Pharmacare Ltd NSE:MONOPHARMA
9 GF Score
Price ₹11.00
! 6 Warning Signs
View Full Analysis

What is Mono Pharmacare Forward Dividend Yield %?

Mono Pharmacare NSE:MONOPHARMA -1.79% 9 Forward Dividend Yield % is 0.00% as of Jul. 08, 2026. GuruFocus rates NSE:MONOPHARMA with a GF Score™ of 9/100. The stock has 6 warning signs investors should review. Among 273 Healthcare Providers & Services companies, Mono Pharmacare ranks worse than 366300% on this metric.

As of today (2026-07-08), the Forward Annual Dividend Yield of Mono Pharmacare is 0.00%.

As of today (2026-07-08), the Trailing Annual Dividend Yield of Mono Pharmacare is 0.00%.

NSE:MONOPHARMA's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.52
* Ranked among companies with meaningful Forward Dividend Yield % only.

Mono Pharmacare's Dividends per Share for the six months ended in Sep. 2025 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Mono Pharmacare  (NSE:MONOPHARMA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Mono Pharmacare Forward Dividend Yield % Related Terms

Mono Pharmacare Forward Dividend Yield % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Mono Pharmacare's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mono Pharmacare Forward Dividend Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mono Pharmacare's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Mono Pharmacare's Forward Dividend Yield % falls into.


NSE:MONOPHARMA
9GF Score
Mono Pharmacare Ltd NSE:MONOPHARMA
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mono Pharmacare Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Mono Pharmacare (NSE:MONOPHARMA) has a Forward Dividend Yield % of 0.00% as of Jul. 08, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Mono Pharmacare and its competitors. According to the industry distribution chart, Mono Pharmacare ranks #999999 out of 273 companies in the Healthcare Providers & Services industry.
Is Mono Pharmacare's Forward Dividend Yield % too high?
Mono Pharmacare's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Mono Pharmacare ranks #999999 out of 273 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mono Pharmacare has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Mono Pharmacare's Forward Dividend Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Mono Pharmacare ranks #999999 out of 273 companies for Forward Dividend Yield %. This places Mono Pharmacare in the lower half of its industry. The industry median Forward Dividend Yield % is 2.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.52, based on 273 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Mono Pharmacare and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mono Pharmacare's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mono Pharmacare stock overvalued right now?
Mono Pharmacare (NSE:MONOPHARMA) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Mono Pharmacare's overall GF Score™ is 9/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Mono Pharmacare (NSE:MONOPHARMA), the current Forward Dividend Yield % is 0.00% as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mono Pharmacare Business Description

Address 1A, Krinkal Apartment, Opposite Mahalaxmi Temple, Paldi, Ahmedabad, GJ, IND, 380007
Mono Pharmacare Ltd distributes a broad range of pharmaceutical products across India. Its portfolio includes antibiotics, antifungal medicines, cough and cold remedies, antacids, analgesics, nutraceuticals, skincare, antiseptics, cardiac and diabetic drugs, and cosmetic items. The company operates through contract manufacturing, sourcing products from various manufacturers and supplying them to healthcare providers and pharmacies. Revenue is generated through the sales and distribution of these pharmaceutical and healthcare products in the Indian market.
9GF Score

Get the complete analysis for NSE:MONOPHARMA

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.00
Price